Special Issue "B and T Cell-Mediated Immunity 2.0"

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cellular/Molecular Immunology".

Deadline for manuscript submissions: 30 June 2022.

Special Issue Editors

Dr. Monica A. McArthur
E-Mail Website
Guest Editor
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Interests: pathogens; cellular immunology; T cell response; infectious diseases; vaccine development; vaccine immunology; Zika and other flaviviruses; enteric pathogens
Special Issues and Collections in MDPI journals
Dr. Franklin Toapanta
E-Mail Website
Guest Editor
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Interests: vaccine; immunology; microbiology; translational research; immune response; conjugated vaccines; therapeutic agents; enteric pathogens; respiratory pathogens; B cell response; T cell response; salmonella and shigella; influenza virus
Special Issues and Collections in MDPI journals

Special Issue Information

Dear Colleagues,

Generation of vigorous cell-mediated immune responses is critical to protection against many infectious diseases. T cells and B cells represent separate but interconnected arms of the adaptive immune response. As such, they are critical in providing long-lasting protection, thanks to the induction of immune memory, following vaccination or natural infection. This Special Issue focuses on T and B cell-mediated immunity as they relate to vaccination and protection against infectious diseases.  The goal is to enhance our knowledge of the important roles that T and B cells play to provide long-lasting protection. Understanding the contributions of T and B cells, as well as their interactions, following vaccination and/or natural infection could provide critical insights that will help further vaccine development.

Dr. Monica A. McArthur
Dr. Franklin Toapanta
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Dr. Monica A. McArthur
Dr. Franklin Toapanta
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Vaccine immunology
  • T-cell mediated immunity
  • B-cell mediated immunity
  • cellular immunology
  • infectious diseases
  • clinical trials
  • translational research
  • animal models

Published Papers

This special issue is now open for submission.
Back to TopTop